The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2015

Filed:

Oct. 09, 2008
Applicants:

Stephen Cusack, Seyssinet-Pariset, FR;

Delphine Gulligay, Voreppe, FR;

Darren Hart, Noyarey, FR;

Franck Tarendeau, Grenoble, FR;

Inventors:

Stephen Cusack, Seyssinet-Pariset, FR;

Delphine Gulligay, Voreppe, FR;

Darren Hart, Noyarey, FR;

Franck Tarendeau, Grenoble, FR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/08 (2006.01); G01N 33/483 (2006.01); C12Q 1/48 (2006.01); B65D 1/02 (2006.01); B65D 79/00 (2006.01);
U.S. Cl.
CPC ...
B65D 1/0223 (2013.01); B65D 79/005 (2013.01); B65D 2501/0036 (2013.01);
Abstract

The present invention relates to soluble fragments of the Influenza virus RNA dependent RNA polymerase subunit PB2 and variants thereof, and crystallized complexes thereof comprising an RNA cap analog. This invention also relates to computational methods using the structural coordinates of said complex to screen for and design compounds that interact with the RNA cap binding pocket. In addition, this invention relates to methods identifying compounds that bind to PB2 polypeptide fragments comprising the RNA cap binding pocket, preferably inhibit the interaction with RNA caps or analogs thereof, by using said PB2 polypeptide fragments, preferably in a high-throughput setting. This invention also relates to compounds and pharmaceutical compositions comprising the identified compounds for the treatment of disease conditions due to viral infections caused by negative-sense single stranded RNA viruses.


Find Patent Forward Citations

Loading…